Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110177790B details a scalable resolution process for diazaspiro[4.5]decane derivatives, offering high enantiomeric excess and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113717178A discloses a scalable method for chiral 7-azabicyclo[2.2.1]heptane intermediates, offering improved purity and cost efficiency for oncology drug manufacturing.
Advanced optical resolution process for 2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidine-1-propanone. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Advanced resolution and racemization process for L-synephrine intermediates. Reduces waste and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN113801027A reveals a high-yield synthesis route for dapoxetine hydrochloride offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN1894224A reveals a superior ethanol-based resolution process for Nefopam, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel benzophenone route for Solifenacin intermediate. Cost-effective, eco-friendly, high purity manufacturing process detailed in patent CN111925266A.
Patent CN112979552A reveals a novel Friedel-Crafts route for Dexmedetomidine HCl, offering 100% purity and superior supply chain stability for pharma manufacturers.
Patent CN1323300A details an improved convergent synthesis for novel antidiabetic compounds. Discover cost-effective manufacturing strategies and high-purity intermediate supply solutions.
Patent CN103755582A details a novel direct resolution of DL-serine using cyclic phosphates. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN111302997A reveals a streamlined one-pot method for Raatinib intermediates, offering significant cost and waste reduction for API manufacturing.
Patent CN101985447A details chiral resolution for tetrabenazine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN112225697B reveals a green chiral resolution method for chloroquine phosphate, offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN109400521B reveals a green, high-yield route for Avibactam intermediates. Discover cost reduction in API manufacturing and scalable supply solutions.
Patent CN100336803C details a scalable resolution method for difluorophenylalanine, offering high purity and cost-effective supply chain solutions for pharma.
Advanced manufacturing process for thrombotic disorder API intermediates. Reduces costs via novel crystallization and resolution techniques described in patent CN1351600A.
Patent CN104529958B details a scalable Ramelteon synthesis. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel three-step synthesis for Ramelteon intermediates ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN110467580A enables high-purity Lesinurad resolution using quinoline alkaloids, ensuring cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN1122030C details a novel D-IP3 synthesis reducing chromatography. Discover cost-effective manufacturing and high-purity inositol phosphate supply solutions.